Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

International cooperation to improve access to and sustain effectiveness of antimicrobials

(2016) Christine Årdal et al.   LANCET

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach

(2016) John H Rex et al.   LANCET INFECTIOUS DISEASES

An international legal framework to address antimicrobial resistance

(2015) Steven J Hoffman et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Strategies for achieving global collective action on antimicrobial resistance

(2015) Steven J Hoffman et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

What Will it Take to Address the Global Threat of Antibiotic Resistance?

(2015) Steven J. Hoffman et al.   JOURNAL OF LAW MEDICINE & ETHICS

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

(2014) Thomas P Van Boeckel et al.   LANCET INFECTIOUS DISEASES

Novel classes of antibiotics or more of the same?

(2011) Anthony RM Coates et al.   BRITISH JOURNAL OF PHARMACOLOGY

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS

Towards new business models for R&D for novel antibiotics

(2011) A.D. So et al.   DRUG RESISTANCE UPDATES

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

(2011) Ellen 't Hoen et al.   Journal of the International AIDS Society